Gene · 8915
Papers2,643
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,643
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Disrupting the Dok3-Card9 Interaction with Synthetic Peptides Enhances Antifungal Effector Functions of Human Neutrophils. | Pharmaceutics | 2023 | 37513967 | PubTator, text mining | PubMed |
| Landscape of Genetic Mutations in Appendiceal Cancers. | Cancers (Basel) | 2023 | 37509254 | PubTator, text mining | PubMed |
| Proteomics Identifies Circulating TIMP-1 as a Prognostic Biomarker for Diffuse Large B-Cell Lymphoma. | Mol Cell Proteomics | 2023 | 37500057 | PubTator, text mining | PubMed |
| In silico identification and in vitro assessment of a potential anti-breast cancer activity of antimicrobial peptide retrieved from the ATMP1 Anabas testudineus fish peptide. | PeerJ | 2023 | 37483971 | PubTator, text mining | PubMed |
| Cytomorphologic, immunophenotypical and molecular features of pancreatic acinar cell carcinoma. | Diagn Cytopathol | 2023 | 37469257 | PubTator, text mining | PubMed |
| Beneficial effect of cerium excess on in situ grown Sr0.86Ce0.14FeO3-CeO2 thermocatalysts for the degradation of bisphenol A. | RSC Adv | 2023 | 37465574 | PubTator, text mining | PubMed |
| Whole-genome sequencing and functional annotation of pathogenic Paraconiothyrium brasiliense causing human cellulitis. | Hum Genomics | 2023 | 37461066 | PubTator, text mining | PubMed |
| Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as an Important Scaffold for Anticancer Drug Discovery-In Vitro and In Silico Evaluation. | Int J Mol Sci | 2023 | 37446136 | PubTator, text mining | PubMed |
| Genomic profiles of renal cell carcinoma in a small Chinese cohort. | Front Oncol | 2023 | 37427096 | PubTator, text mining | PubMed |
| Surgical management of deep dermatophytosis in a patient with CARD9 deficiency. | J Surg Case Rep | 2023 | 37426045 | PubTator, text mining | PubMed |
| Clinical relevance of molecular aspects in extranodal marginal zone lymphoma: a critical appraisal. | Ther Adv Med Oncol | 2023 | 37389189 | PubTator, text mining | PubMed |
| Mixed acinar-neuroendocrine carcinoma of the pancreas with positive for microsatellite instability: a case report and review of the literature. | Surg Case Rep | 2023 | 37386324 | PubTator, text mining | PubMed |
| Hepatotoxic mechanism of cantharidin: insights and strategies for therapeutic intervention. | Front Pharmacol | 2023 | 37383714 | PubTator, text mining | PubMed |
| Precursory or early lesions of follicular lymphoma: clinical features, pathology, and genetics. | J Clin Exp Hematop | 2023 | 37380471 | PubTator, text mining | PubMed |
| CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas. | PLoS One | 2023 | 37379306 | PubTator, text mining | PubMed |
| Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests (NAATs) and Its Integration into Nanomedicine and Microfluidic Devices as Point-of-Care Testing (POCT). | Int J Mol Sci | 2023 | 37373381 | PubTator, text mining | PubMed |
| A nomogram for predicting the rapid progression of diffuse large B-cell lymphoma established by combining baseline PET/CT total metabolic tumor volume, lesion diffusion, and TP53 mutations. | Cancer Med | 2023 | 37366281 | PubTator, text mining | PubMed |
| Case of a Patient With Pancreatic Cancer With Sporadic Microsatellite Instability Associated With a BRAF Fusion Achieving Excellent Response to Immunotherapy. | JCO Precis Oncol | 2023 | 37364232 | PubTator, text mining | PubMed |
| Anti-Tumor Strategies by Harnessing the Phagocytosis of Macrophages. | Cancers (Basel) | 2023 | 37345054 | PubTator, text mining | PubMed |
| Primary Cutaneous Follicle Center Lymphoma of the Eyelid in a Young Man. | Ophthalmic Plast Reconstr Surg | 2023 | 37338339 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8915/papers?page=11